The Challenge
A pharmaceutical research team required 450 verified oncology specialists and patient cohorts with confirmed rare disease diagnoses across US, UK, Germany, France, and Japan. Regulatory-grade verification required. HIPAA compliance mandatory.
Our Approach
Oncologist recruitment via KOL networks and medical association partnerships. License verification against NPI (US) and GMC (UK) databases. Patient cohorts verified via prescription history and advocacy group partnerships. HIPAA-compliant data vaults deployed. Native-language screeners for Germany, France, Japan.
Results
450 KOL completes. 98% incidence rate achieved against target profile. 100% license verification. 6-week delivery. Zero compliance incidents.
Client Outcome
Fully anonymised regulatory-grade dataset delivered with verification audit trail. Study passed the pharma client's internal data governance review on first submission.
Project Specifications
- Markets Covered: United States, United Kingdom, Germany, France, Japan.
- Audience Recruited: Medical Oncologists, Oncology Clinic Directors, and Rare Disease Patients.
- Session Formats: 60-minute qualitative video interviews (IDIs).
- Compliance Standard: HIPAA compliant data vault, GDPR registry checked.
Plan a Similar Study
Ready to execute high-integrity global B2B or consumer research? Contact our fieldwork consultants to design a tailored feasibility plan for your target audience.
Plan a similar study →